Viewing Study NCT02690103


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2025-12-30 @ 12:44 PM
Study NCT ID: NCT02690103
Status: COMPLETED
Last Update Posted: 2016-02-24
First Post: 2016-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV
Sponsor: Cairo University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C, Chronic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HCV View
None Viremia View
None Arabinoxylan View
None Biobran View
None PEG interferon View